| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,055 | 46,831 | 44,809 | 51,500 | | Cost of Revenue | 28,897 | 28,943 | 28,719 | 30,621 | | | Gross Profit | 20,158 | 17,888 | 16,090 | 20,879 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,197 | 8,852 | 8,586 | 12,235 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,837 | 1,867 | 1,903 | 1,003 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,124 | 7,169 | 5,601 | 7,641 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56 | (954) | (753) | (515) | | Earnings Before Interest And Taxes | 9,180 | 6,215 | 4,848 | 7,126 | | Interest Expense | 18 | 33 |
-
| 22 | | Income Before Tax | 9,162 | 6,182 | 4,848 | 7,104 | | Income Tax Expense | 278 | 126 | (153) | 134 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,884 | 6,056 | 5,001 | 6,970 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (176) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,884 | 6,056 | 5,001 | 6,794 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,884 | $6,056 | $5,001 | $6,794 |
|
1.48% Nasdaq 
Income Statement
